All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Retrospective analysis of 118 patients with cutaneous T-cell lymphomas: a single-center experience

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F22%3A00013427" target="_blank" >RIV/00023736:_____/22:00013427 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/22:10445165 RIV/00064165:_____/22:10445165

  • Result on the web

    <a href="https://doi.org/10.3389/fonc.2022.884091" target="_blank" >https://doi.org/10.3389/fonc.2022.884091</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3389/fonc.2022.884091" target="_blank" >10.3389/fonc.2022.884091</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Retrospective analysis of 118 patients with cutaneous T-cell lymphomas: a single-center experience

  • Original language description

    Cutaneous T-cell lymphomas (CTCL) represent rare non-Hodgkin lymphomas (NHL) with an incidence less than 1 per 100,000 inhabitants. The most common type of CTCL is mycosis fungoides (MF), which represents approximately 60% of all CTCL, followed by Sézary syndrome (SS), approximately 5%. We retrospectively analyzed the outcome of 118 patients with MF (n=96) and SS (n=22) treated between the years 1998 and 2021 at the Charles University General Hospital in Prague, Czech Republic. In conclusion, our analysis of 118 real world cohort of consecutive CTCL patients treated at the single center confirmed the efficacy of immune response modifiers and underlines the urgent need for ample implementation of innovative agents and their combinations into earlier lines of therapy.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30205 - Hematology

Result continuities

  • Project

    <a href="/en/project/NV19-08-00144" target="_blank" >NV19-08-00144: Humanized patient-derived murine xenografts for experimental therapy of hematologic malignancies and for the study of in vivo acquired drug-resistance</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Frontiers in oncology

  • ISSN

    2234-943X

  • e-ISSN

  • Volume of the periodical

    12

  • Issue of the periodical within the volume

    [June]

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    9

  • Pages from-to

  • UT code for WoS article

    000813892100001

  • EID of the result in the Scopus database

    2-s2.0-85133452445